IA Trial Radar | ||
|---|---|---|
El ensayo clínico NCT05442671 (iTONE) para Hipertensión pulmonar está reclutando. Consulte la vista de tarjeta del Radar de Ensayos Clínicos y las herramientas de descubrimiento de IA para conocer todos los detalles. O haga cualquier pregunta aquí. | ||
iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH
Recent trials have demonstrated improved exercise performance and functional class in adults with PH undertaking prescribed exercise training. Pediatric data are limited to a single, small study in which exercise performance improved after a 16-week home exercise program. That intervention did not include skeletal muscle assessment, wearable activity monitors, or specified behavioral theory, as does the current proposal. The characteristics of the optimal PH exercise program are not clear as prior studies often failed to provide sufficient detail to enable reproducibility. Most programs have been hospital-based, some with additional at-home components. Duration has varied from 4-15 weeks. Programs have included aerobic, resistance, and respiratory exercise. Patient adherence has been inconsistently assessed. While wearable activity monitors have been used to assess activities of daily living of PH patients, they have not been employed in PH exercise programs. In youth, practical concerns of developmental differences, access to facilities or equipment, and parental time commitment must be considered, and home programs may be critical to avoiding missed school and work.
Newer technologic advances enable remote monitoring of physical activity in the home setting. Wearable accelerometer sensors with wireless transmission capabilities allow us to measure relevant endpoints from a patient's daily life. In this study, participants will undergo baseline assessment of muscle mass and strength and quality of life prior to a 16-week home exercise program, enriched by mobile health technology. Investigators will use a wrist-worn accelerometer paired with periodic text messages to measure activity, obtain daily downloads, and engage patients to promote adherence. Assessment of muscle mass and strength and quality of life will be repeated after the intervention. This real-time monitoring of adherence and feedback to the patient represent fundamental changes in PH treatment paradigms that can significantly enhance efficacy.
Home Exercise Training in Pediatric Pulmonary Hypertension
- iTONE
- 20-018168
- 1K23HL150337-01A1 (Subvención/contrato NIH (EE. UU.))
| Grupo de participantes | Intervención/Tratamiento |
|---|---|
OtrosHome exercise intervention * Personalized 16 week home exercise program - aerobic exercise for 20 minutes per day/4 days per week and light resistance exercise using resistance bands 3 days per week.
* Aerobic sessions will include walking, biking, or light jogging, depending on access to facilities/equipment and weather.
* Smartwatch for the length of the intervention and a heart rate monitor during exercise sessions.
* Max heart rate prescribed will be 80% of that on recent cardiopulmonary exercise test (at most 150 beats/min).
* Heart rate monitor will sync with the smartwatch.
* Activity and heart rate data will be transmitted to the study team via a data hub connected to the participant's home internet modem several times per week.
* Periodic text messaging to remind participants to wear the watch, sync the data, or adhere to heart rate goals, to ask about symptoms, or to support activity progress.
* Multiple ways to contact the study team with questions or concerns. | Intervención de ejercicio 16-week home exercise intervention, enriched by mobile health technology |
| Medida de resultado | Descripción de la medida | Periodo de tiempo |
|---|---|---|
Change in moderate to vigorous physical activity (MVPA) | Change in MVPA (min/day) will be measured by smartwatch accelerometer from baseline over the course of the intervention | Pre-exercise intervention and Post intervention (within 2 weeks of completion of the 16-week exercise intervention) |
| Medida de resultado | Descripción de la medida | Periodo de tiempo |
|---|---|---|
Change in leg lean mass Z-score (LLMZ) | LLMZ will be measured by densitometry. LLMZ is a percentile score with scores -2 to 2 considered typical | Pre-exercise intervention and Post intervention (within 2 weeks of completion of the 16-week exercise intervention) |
Change in muscle strength | Upper extremity strength will be measured by handgrip dynamometer. Lower extremity strength will be measured by Biodex across the knee and ankle | Pre-exercise intervention and Post intervention (within 2 weeks of completion of the 16-week exercise intervention) |
Change in quality of life score | Score measured by completion of PedsQL questionnaire. Scores range from 0-100 with higher scores indicating better quality of life | Pre-exercise intervention and Post intervention (within 2 weeks of completion of the 16-week exercise intervention) |
- Age 8-18 years
- PH World Health Organization (WHO) diagnostic groups 1, 2, 3, or 4 (pulmonary arterial hypertension, PH due to left heart disease, PH due to lung disease, chronic thromboembolic PH)
- WHO functional class I or II
- Ambulatory status
- Mean pulmonary to systemic arterial pressure ratio <0.75 on most recent cardiac catheterization
- Stable PH medication regimen for 3 months prior to the intervention
- Home Wifi connection
- Mobile device in family capable of receiving text messages
- WHO functional class III or IV
- Single ventricle physiology
- Moderate to severe renal disease (>stage 3)
- Severe hepatic impairment [aspartate aminotransferase (AST)/alanine transaminase (ALT) > 2x upper limit of normal]
- Current pregnancy
- Significant developmental delay/inability to comply with verbal instructions to complete the study procedures
Pennsylvania